Cullinan Oncology Inc.
(CGEM)
undefined
undefined%
At close: undefined
11.75
-0.17%
After-hours Dec 13, 2024, 04:15 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -153.16M | 109.19M | -67.48M | -59.46M | -21.65M | -14.19M |
| Depreciation & Amortization | 310.00K | 93.00K | 53.00K | 62.00K | 70.00K | 43.00K |
| Stock-Based Compensation | 30.44M | 27.96M | 24.38M | 14.91M | 17.00K | - |
| Other Working Capital | -172.00K | 11.69M | 1.29M | 1.27M | -504.00K | 120.00K |
| Other Non-Cash Items | -11.52M | -275.08M | 67.00K | 7.63M | 539.00K | 252.00K |
| Deferred Income Tax | - | - | 3.10M | 233.00K | -4.00K | - |
| Change in Working Capital | -339.00K | 11.18M | -3.54M | 6.85M | 135.00K | 345.00K |
| Operating Cash Flow | -134.28M | -126.66M | -43.43M | -29.77M | -20.90M | -13.55M |
| Capital Expenditures | -208.00K | -1.13M | -589.23K | -10.00K | -20.00K | -261.00K |
| Acquisitions | -36.01K | 275.00M | 923.00K | 1.45M | - | - |
| Purchase of Investments | -373.38M | -377.92M | -525.81M | -69.76M | -35.38M | - |
| Sales Maturities Of Investments | 409.40M | 352.93M | 192.04M | 62.90M | - | - |
| Other Investing Acitivies | 36.01K | 91.00K | -333.77K | -5.41K | -35.38K | - |
| Investing Cash Flow | 35.81M | 248.97M | -333.77M | -5.42M | -35.40M | -261.00K |
| Debt Repayment | 1.82M | -2.20M | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -378.00K | - |
| Dividend Paid | - | - | - | - | - | - |
| Other Financial Acitivies | 538.00K | -23.73M | 1.52M | 138.88M | 85.72M | -30.00K |
| Financial Cash Flow | 40.75M | -25.93M | 268.78M | 140.14M | 85.72M | -29.00K |
| Net Cash Flow | -57.72M | 96.38M | -108.42M | 104.95M | 29.42M | -13.84M |
| Free Cash Flow | -134.48M | -127.80M | -44.02M | -29.78M | -20.92M | -13.81M |